The TCR Vβ repertoire usage of T-cells from cord blood induced by chronic myelogenous leukemia associated antigen

References

• Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176–181.
   PubMedGoogle Scholar
• Romero P, Cerottinl JC, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998;4:305–312.
   PubMedGoogle Scholar
• Li Y, Li R, Yang L, Chen S, Zhang Y. Study on clonal expansion and specific cytotoxicity of autologous and allogeneic T cells induced by M2a cells. Blood 2001;99(11):122a.
   Google Scholar
• Serrano D, Monteiro J, Allen SL, Kolitz J, Schulman P, Lichtman SM, Buchbinder A, Vinciguerra VP, Chiorazzi N, Gregersen PK. Clonal expansion within the CD4+CD57+ and CD8+CD57+T cell subsets in chronic lymphocytic leukemia. J Immunol 1997;158:1482–1489.
   PubMed Web of Science ®Google Scholar
• Rezvany MR, Jeddi-Tehrani M, Osterborg A, Kimby E, Wigzell H, Mellstedt H. Oligoclonal TCR BV gene usage in B-cell chronic lymphocytic leukemia: Major perturbations are preferentially seen within the CD4 T-cell subset. Blood 1999;94:1063–1069.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Kernan NA, Steinbuch M, Broxmeyer HE, Gluckman E. Allogeneic sibling umbilical-cord-blood trans-plantation in children with malignant and non-malignant disease. Lancet 1995;346:214–219.
   PubMed Web of Science ®Google Scholar
• Wagner JE, Rosenthal J, Sweetman R, Shu XO, Davies SM, Ramsay NK, McGlave PB, Sender L, Cairo MS. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996; 88:795–802.
   Google Scholar
• Garderet L, Dulphy N, Douay C, Chalumeau N, Schaeffer V, Zilber MT, Lim A, Even J, Mooney N, Gelin C, Gluckman E, Charron D, Toubert A. The umbilical cord blood alphabeta T-cell repertoire: Characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998;91:340–346.
   Google Scholar
• Toubert A, Douay C, Chalumeau N, Garderet L, Dulphy N, Zilber MT, Gelin C, Mooney N, Charron D. Effects of superantigenic stimulation on the cord blood alphabeta T cell repertoire. Bone Marrow Transplant 1998;22\(Suppl. 1): S36—S38.
   PubMedGoogle Scholar
• Koyama S. Augmented human tumor cytolytic activity of peripheral blood lymphocytes and cells from a mixed lymphocyte/tumor culture activated by interleukin-12 plus interleukin-2, and the phenotypic characterization of the cells in patients with advanced carcinoma. J Cancer Res Chin Oncol 1997;123:478–484.
   PubMed Web of Science ®Google Scholar
• Meij P, Bloemena E, Palmen N, Brink A, Vervoort MB, Meijer CJ, Middeldorp JM. Functional CD4+ and CD8+T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines. Cell Immunol 2001;208: 25–33.
   PubMed Web of Science ®Google Scholar
• Yomda P, Firat H, Garcia-Pons F, Garcia Z, Gourru G, Vernant JP, Lemonnier FA, Leblond V, Langlade-Demoyen P. Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Chin Invest 1998;101: 2290–2296.
   PubMed Web of Science ®Google Scholar
• Mannering SI, McKenzie JL, Fearnley DB, Hart DN. HLA-DR1-restricted bcr-abl (b3a2)-specific CD4+T lymphocytes respond to dendritic cells pulsed with b3a2 peptide and antigen-presenting cells exposed to b3a2 containing cell lysates. Blood 1997;90:290–297.
   PubMed Web of Science ®Google Scholar
• Tanaka F, Fujie T, Go H, Baba K, Mori M, Takesako K, Akiyoshi T. Efficient induction of antitumor cytotoxic T lymphocytes from a healthy donor using HLA-A2-restricted MAGE-3 peptide in vitro. Cancer Immunol Immunother 1997;44: 21–26.
   PubMed Web of Science ®Google Scholar
• Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 1994;153:2807–2818.
   PubMed Web of Science ®Google Scholar
• Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy". J Exp Med 1994;179: 609–618.
   PubMed Web of Science ®Google Scholar
• van den Beemd R, Boor PP, van Lochem EG, Hop WC, Langerak AW, Wolvers-Tettero IL, Hooijkaas H, van Dongen JJ. Flow cytometric analysis of the Vbeta repertoire in healthy controls. Cytometry 2000;40:336–345.
   PubMedGoogle Scholar
• Alfani E, Migliaccio AR, Sanchez M, Passarelli AM, Migliaccio G. Characterization of the T cell receptor repertoire of neonatal T cells by RT-PCR and single strand conformation polymorphism analysis. Bone Marrow Trans-plant 2000;26:83–89.
   PubMed Web of Science ®Google Scholar
• Marolleau JP, Ternaux B, Dal Cortivo L, Brossard Y, Gluckman E, Benbunan M. T cell repertoire of human umbilical cord blood. Bone Marrow Transplant 1998; 22(Suppl 1):539–540.
   Google Scholar
• Rezvany MR, Jeddi-Tehrani M, Wigzell H, Osterborg A, Mellstedt H. Leukemia-associated monoclonal and oligoclo-nal TCR-BV use in patients with B-cell chronic lymphocytic leukemia. Blood 2003;101 :1063–1070.
   PubMed Web of Science ®Google Scholar
• Heike M, Duchmann R, May E, Schulze-Bergkamen H, Schmitt U. Meyer zum Buschenfelde KH. Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggest a limited set of immunodominant sarcoma antigens. Int J Cancer 1997;72: 403–407.
   PubMed Web of Science ®Google Scholar
• Jahn B, Bergmann L, Weidmann E, Brieger J, Fenchel K, Schwulera U, Hoelzer D, Mitrou PS. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autoulogous cytotoxicity. Leuk Res 1995;19:73–82.
   PubMed Web of Science ®Google Scholar
• Li Y. Leukemia associated clonal expansion TCR V13 subfamily T cells. Hematology 2003;8:375–384.
   PubMedGoogle Scholar
• Orsini E, Alyea EP, Schlossman R, Canning C, Soiffer RJ, Chillemi A, Neuberg D. Chaanges in T cell receptor repertoire associated with graf-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusion. Bone Marrow Transplant 2000;25: 623–632.
   PubMed Web of Science ®Google Scholar
• Claret EJ, Alyea EP, Orsini E, Pickett CC, Collins H, Wang Y, Neuberg D, Soiffer RJ, Ritz J. Charaterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Chin Invest 1997;100:855–866.
   PubMed Web of Science ®Google Scholar
• Jurickova I, Waller EK, Yeager AM, Boyer MW. Generation of alloreactive anti-leukemic cytotoxic T lymphocytes with attenuated GVHD properties from haploidentical parents in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 2002;30:687–697.
   PubMed Web of Science ®Google Scholar
• Currier JR, Deulofeut H, Barron KS, Kehn PJ, Robinson MA. Mitogens, superantigens, and nominal antigens elicit dis-tinctive patterns of TCRB CDR3 diversity. Hum Immunol 1996;48: 39–51.
   PubMed Web of Science ®Google Scholar
• Osman Y, Takahashi M, Zheng Z, Toba K, Liu A, Furukawa T, Narita M, Aizawa Y, Koike T, Shibata A. Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: Its applicability for antileukemia immunother-apy. J Exp Chin Cancer Res 1999;18:485–492.
   PubMed Web of Science ®Google Scholar
• Maeda M, Otsuka T, Kimura N, Kozu T, Fukuyarna T, Uchida N, Sugio Y, Itoh Y, Eno T, Inaba S, Niho Y. Induction of MTG8-specific cytotoxic T-cell lines: MTG8 is probably a tumour antigen that is recognized by cytotoxic T cells in AML1-MTG8-fused gene-positive acute myelogenous leu-kaemia. Br J Haematol 2000;111: 570–579.
   PubMed Web of Science ®Google Scholar
• Azuma T, Makita M, Ninomiya K, Fujita S, Harada M, Yasukawa M. Identification of a novel WT1-derived peptide which induces human leucocyte antigen-A24-restricted anti-leukaemia cytotoxic T lymphocytes. Br J Haematol 2002; 116:601–603.
   PubMed Web of Science ®Google Scholar
• Hoffmann TK, Loftus DJ, Nakano K, Maeurer MJ, Chikamatsu K, Appella E, Whiteside TL, De Leo AB. The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264–272) epitope. J Immunol 2002;168: 1338–1347.
   PubMed Web of Science ®Google Scholar
• Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA. Specific human cellular immunity to BCR-ABL oncogene-derived peptides. Blood 1996;87:3587–3592.
   PubMed Web of Science ®Google Scholar